文献速递眼底病与葡萄膜炎

视网膜下脂质小球的多模态影像特征与临床意义

Multimodal Imaging Features and Clinical Relevance of Subretinal Lipid Globules.
PubMed 文献 · Am J Ophthalmol · 2020-09-09

该回顾性队列研究分析了39例(49眼)视网膜下脂质小球(SLG)患者的多模态影像,发现SLG在彩色眼底照相和近红外反射中不可见,在OCT B扫描上表现为31-157 μm圆形低反射结构伴特征性高透射尾。SLG多见于因1型黄斑新生血管(MNV)接受抗VEGF治疗的AMD眼(91.1%),且既往注射次数与SLG数量正相关。

要点

  • SLG在OCT B扫描上呈圆形低反射结构伴高透射尾,彩照和NIR不可见。
  • SLG最常见于AMD继发1型MNV接受抗VEGF治疗的眼(91.1%)。
  • 既往抗VEGF注射次数与SLG数量正相关,部分眼SLG先于渗出体征出现。

核心结论

  • SLG是OCT上新识别的特征,常见于AMD继发1型MNV接受抗VEGF治疗的眼,表现为小圆形低反射结构伴特征性高透射尾。

研究设计与样本

  • 回顾性队列研究,纳入39例(49眼)显示SLG的患者,评估临床数据和多模态影像特征。
  • 患者接受彩色眼底照相、近红外反射(NIR)、谱域(SD)和扫频源(SS)OCT及OCT血管成像检查。
  • 使用体外体模模型模拟水、矿物油和英脱利匹特液滴的OCT光学特性,探究SLG下方高透射尾的光学机制。

主要发现

  • SLG在彩色眼底照相和NIR图像中不可见。
  • SD-OCT和SS-OCT B扫描上,SLG表现为31-157 μm、圆形、低反射结构,伴特征性高透射尾。
  • En face OCT上,SLG表现为小圆形低反射结构。
  • SLG最常见于AMD继发1型MNV的眼(91.1%),其中93.3%正在接受玻璃体腔抗VEGF治疗(中位注射15次),平均随访52.6个月。
  • 既往注射次数与SLG数量正相关;66.7%的病例中MNV检出先于SLG出现。

关键数值与推荐

  • SLG在OCT B扫描上表现为31-157 μm圆形低反射结构伴高透射尾。
  • 91.1%的SLG见于AMD继发1型MNV眼,其中93.3%接受抗VEGF治疗(中位15次注射)。
  • 49%的眼SLG呈>10个的簇状分布;38.8%的眼SLG覆盖于1型MNV上,44.9%的眼SLG位于病灶边缘附近。

临床怎么用

  • 在OCT上识别SLG(小圆形低反射结构伴高透射尾)有助于将其与其他视网膜结构区分。
  • 对AMD继发1型MNV接受抗VEGF治疗的眼,SLG的出现可能与既往注射次数相关,需关注其临床意义。
  • 在非渗出性1型MNV随访中,SLG可能先于其他渗出影像体征出现,提示需密切监测。

局限性

  • 回顾性研究设计。
  • 样本量有限(39例,49眼)。
  • SLG的光学特征基于体外体模模型,可能不完全代表在体情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe the presence of subretinal lipid globules (SLG), analyze the multimodal imaging features inherent in their optical properties, and provide a means to distinguish them from other retinal structures and clinical signs. DESIGN: Retrospective cohort study. METHODS: The clinical data and multimodal imaging features of 39 patients (49 eyes) showing SLG were evaluated. Patients underwent color fundus photography, near-infrared reflectance (NIR), spectral-domain (SD) and swept-source (SS) optical coherence tomography (OCT) and OCT angiography. In vitro phantom models were used to model OCT optical properties of water, mineral oil, and intralipid droplets and to investigate the optical mechanisms producing hypertransmission tails beneath SLG. RESULTS: The SLG were not visible in color fundus photographs or in NIR images. With both SD- and SS-OCT B-scans, SLG appeared as 31-157 μm, round, hyporeflective structures demonstrating a characteristic hypertransmission tail previously described with lipid globules found in the choroid and in neovascular membranes. Similarly, with en face OCT, SLG appeared as small, round, hyporeflective structures. SLG were encountered most often in eyes with neovascular age-related macular degeneration (AMD) that had type 1 macular neovascularization (MNV) (91.1%). Of those eyes, 93.3% were receiving intravitreal antivascular endothelial growth factor (VEGF) therapy (median of 15 injections) with a mean follow-up of 52.6 months. The number of prior injections positively correlated with the number of SLG. The detection of MNV preceded the presence of SLG in 66.7% of cases. En face OCT showed that, in many eyes (49%), SLG appeared in clusters of >10. In 38.8% of eyes, SLG were found overlying type 1 MNV, and in 44.9% of eyes, often those with more numerous SLG, the SLG were located near the lesion border. In 2 eyes with AMD followed for nonexudative type 1 MNV, SLG were detected prior to the detection of other imaging signs of exudation. SLG were observed in several other exudative macular diseases. Phantom models demonstrated that the hypertransmission tail beneath SLG is related to a lensing effect produced by these hyporeflective spherical structures. CONCLUSIONS: SLG are a newly recognized OCT feature frequently seen in eyes receiving intravitreal anti-VEGF therapy for type 1 MNV due to AMD. OCT B-scans show SLG as small, round, hyporeflective structures with a characteristic hypertransmission tail. This OCT signature is influenced by the OCT focal plane, and it relates to reduced signal attenuation through oil and a lensing effect created by a higher refractive index compared to surrounding tissue.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Fernández-Avellaneda P, Freund KB, Wang RK, et al. Multimodal Imaging Features and Clinical Relevance of Subretinal Lipid Globules. Am J Ophthalmol. 2020. PMID: 32918902. doi:10.1016/j.ajo.2020.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。